Tissue Regenix Group plc

Company Profile

Company website
Sector
Pharmaceuticals & Biotechnology (Biotechnology)
Description
Tissue Regenix Group plc (AIM: TRX) is a pioneering, international medical technology company focused on the development of regenerative products using two platform technologies, dCELL®, addressing soft tissue needs, and BioRinse™, providing inductive bone allografts.

Investor Access

05 Sep
Event information

The Company will announce its interim results for the six months ended 30 June 2023 on Tuesday 5 September 2023 at 16:30 BST.

Investors can sign up to Investor Meet Company for free and add to meet Tissue Regenix Group via the following link:

https://www.investormeetcompany.com/tissue-regenix-group-plc/register-investor
Venue
Online
Time

Tuesday 5 September 2023 at 16:30 BST

Financial Calendar
 Event Date
Year End31 December
Half  Year End30 June
Preliminary Results*June
Interim Results*5 September
AGM*June

* Months based on previous announcements of this kind